SCHEMBL4771202

SCHEMBL4771202

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(N(C=O)Cc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
LMNA P02545 2/20 0.37
POLB P06746 1/20 0.37
PTGER1 P34995 2/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
MMP2 P08253 3/20 0.36
MMP9 P14780 3/20 0.36
ALDH1A1 P00352 1/20 0.35
RECQL P46063 1/20 0.34
NR3C1 P04150 1/20 0.34
SERPINE1 P05121 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4773541 0.88 GAA (0.42) GAALMNAMMP2MMP9ALDH1A1
SCHEMBL4775060 0.87 GAA (0.39) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4772347 0.86 GAA (0.37) GAALMNAPOLBPTGER1HDAC1
SCHEMBL4775247 0.83 GAA (0.48) GAALMNAALDH1A1KDM4EMAPT
SCHEMBL4776710 0.83 GAA (0.43) GAALMNAPOLBALDH1A1KDM4E
SCHEMBL4773507 0.82 GAA (0.42) GAALMNAALDH1A1KDM4EMAPT
SCHEMBL4777347 0.80 NR1H4 (0.39) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4776590 0.79 GAA (0.42) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4768251 0.79 GAA (0.42) GAALMNAPOLBALDH1A1MAPT
SCHEMBL4771377 0.78 GAA (0.40) GAALMNAPOLBALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 GAA 466/4885LMNA 1022/4885POLB 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.